Lexicon Pharmaceuticals lexpharma.com


Public list: BIO 2016 (619) Pharma Startups (4732)

Lexicon Pharmaceuticals, Inc. - Translating the human genome to fight disease... one gene at a time.

Lexicon Pharmaceuticals, Inc. - Translating the human genome to fight disease... one gene at a time.

Company (IPO / Went public)

Phone: 281-863-3000

Fax:

8800 Technology Forest Place

The Woodlands, 77381
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lexicon Pharmaceuticals $481M Aug 6, 2007
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lexicon Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Idenix Pharmaceuticals

Cambridge, Massachusetts, United States
AcquiredIdenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix is headquartered in Cambridge, Massachusetts (USA). The Company's clinical development operations and drug discovery operations are conducted in Cambridge and in the Company's European laboratories in Montpellier, France. Idenix's current focus is on the treatment of patients with hepatitis C infection.Login to see details

Bolder BioTechnology

Boulder, Colorado, United States
Alive / ActiveBolder BioTechnology, Inc. uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties. Most protein pharmaceuticals are rapidly eliminated by the body, which limits their effectiveness and requires that they be administered by frequent, often daily, injection. The company's products are designed to last longer in the body, which aims to allow them to be administered less frequently, e.g., once per week to once per month, and maximi...Show allLogin to see details
See all 16 competitors